“…FQs have been shown to be effective in the treatment against Chlamydia spp., Staphylococcus aureus , E. coli , Salmonella spp., and mycoplasma spp., which usually cause septic arthritis ( Guardabassi, Jensen & Kruse, 2009 ). Enro and Mar were approved for veterinary use for dogs in 1998 ( Babaahmady & Khosravi, 2011 ; Sárközy, 2001 ; Babaahmady & Khosravi, 2011 ; Pallo-Zimmerman, Byron & Graves, 2010 ), respectively. With different substituents at the R-1, R-7, and X-8 positions on the quinolone central ring system, they have a large difference in terms of molecular structure, antibacterial activity, spectrum, and pharmacokinetic properties ( Andriole, 2005 ; Domagala, 1994 ; Farca et al, 2007 ; Hong, Kim & Kim, 1997 ; Pallo-Zimmerman, Byron & Graves, 2010 ; Peterson, 2001 ; Šeol, 2005 ).…”